Average Co-Inventor Count = 6.31
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (11 from 4,179 patents)
2. Abbvie Inc. (6 from 822 patents)
3. Other (1 from 832,912 patents)
18 patents:
1. 9796708 - Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
2. 9283222 - Inhibitors of poly(ADP-ribose)polymerase
3. 9073922 - Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors
4. 8697736 - 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
5. 8546368 - Pyrazoloquinolones are potent PARP inhibitors
6. 8466150 - Inhibitors of poly(ADP-ribose)polymerase
7. 8450320 - Pyrrolopyrazinone inhibitors of kinases
8. 8383623 - Phthalazin-(2H)-one inhibitors of kinases
9. 8217070 - 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors
10. 8067613 - Benzimidazole poly(ADP ribose)polymerase inhibitors
11. 7999117 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
12. 7728026 - 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
13. 7595406 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
14. 7550603 - 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors
15. 7462724 - Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors